Amylyx Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Amylyx Pharmaceuticals's estimated annual revenue is currently $28.2M per year.
- Amylyx Pharmaceuticals's estimated revenue per employee is $108,084
- Amylyx Pharmaceuticals's total funding is $202.2M.
- Amylyx Pharmaceuticals has 261 Employees.
- Amylyx Pharmaceuticals grew their employee count by 61% last year.
Amylyx Pharmaceuticals Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Amylyx Pharmaceuticals?
Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.keywords:N/A
Number of Employees
Employee Growth %
Amylyx Pharmaceuticals News
Shares of Amylyx Pharmaceuticals ( AMLX -8.81% ), a clinical-stage biopharmaceutical company, are tanking in response to comments from the...
Shares of Amylyx Pharmaceuticals lost more than half of their value after the Food and Drug Administration issued a skeptical analysis of...
... convening a meeting of outside experts today to review clinical data on an experimental treatment for ALS from Amylyx Pharmaceuticals.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|